Estimated dispatch within 1 to 2 working days.
Local anaesthetic injection. For minor surgical procedures including dehorning and debudding in cattle. POM-VPS.
A clear, colourless solution for injection containing:
Procaine Hydrochloride 50 mg/ml
Adrenaline (Epinephrine) (as Adrenaline Acid Tartrate) 0.02 mg/ml
Chlorocresol Ph. Eur. (as preservative) 1 mg/ml
Sodium Metabisulphite E223 (as antioxidant) 1 mg/m
A local anaesthetic injection for minor surgical procedures, including dehorning and disbudding in cattle.
By subcutaneous injection. Cattle: 2 to 5ml.
Meat: Zero days
Milk: Zero days
Do not administer by intravenous, intra-articular or epidural injection.
Procaine may inhibit the action of sulphonamides and their concurrent administration should be avoided.
Adverse Reactions: If you notice any serious effects or other effects not mentioned in this publication, please inform your veterinary surgeon.
Advice On Correct Administration: Avoid excessive broaching of the closure.
Do not store above 25°C. Protect from light.
Special Warnings: Care should be taken to avoid accidental self-injection.
In the event of self injection, seek medical attention and show the label to the physician.Immediately wash off any splashes to the eyes or skin with copious amounts of water.
Seek medical attention if irritation occurs.
Wash hands after use.
Following withdrawal of the first dose, use the product within 28 days. Write the date to discard unused solution in the space provided on the label.
Dispose of any unused product and empty containers in accordance with guidance from your local waste regualtion authority.
For Animal Treatment Only
Keep out of reach and sight of Children
1. IDENTIFICATION OF SUBSTANCE / PREPARATION AND OF COMPANY / UNDERTAKING
Product Name Adrenacaine Injection
Supplier Norbrook Laboratories Ltd,
Station Works, Newry, Co.Down,
N.Ireland, BT35 6JP.
Telephone No. +44 (0) 28 3026 4435
Fax No. +44 (0) 28 3026 1721
Emergency Telephone +44 (0) 28 3026 4435
2. HAZARDS IDENTIFICATION
Physical and Chemical Hazards : Not classified as dangerous under EC Directives 67/548/EEC,
88/379/EEC or 99/45/EC.
Environmental Hazards : None known
Adverse Human Health Effects : There are no known adverse effects of exposure to Adrenacaine
3. COMPOSITION / INFORMATION ON INGREDIENTS
Substance/Preparation : Preparation
Active Ingredients : Procaine Hydrochloride
Chlorocresol ( as antimicrobial preservative )
Description : Local anaesthetic ( procaine )
Circulatory system stimulant ( adrenaline )
Chemical Family : Cardiac Glycoside ; Sympathiomimetic
4. FIRST AID MEASURES
Inhalation : Remove to fresh air. If any signs or symptoms occur or persist seek medical advice.
Skin Contact : Wash thoroughly with soap and water. Remove contaminated clothing and wash before reuse.
Eyes Contact : Immediately flush eyes with copious amounts of water for at least 15
minutes. If irritation persists, seek medical attention.
Ingestion : Do not induce vomiting. Seek medical attention.
5. FIRE FIGHTING MEASURES
Extinguishing media: Use carbon dioxide, dry chemical or alcohol-resistant foam spray extinguishers.
Use water spray to cool fire-exposed containers. A fine water mist may be used
to smother or to disperse vapours.
Fire and explosion hazards: None.
6. ACCIDENTAL RELEASE MEASURES
Personal Precautions : Provide good ventilation. Prevent skin and eye contact.
Environmental Precautions: Keep away from drains, surface-water, ground-water and soil.
Method for Clean-up : Absorb small spills on spill pillows, sand, sawdust or other suitable absorbing
7. HANDLING AND STORAGE
Handling : Avoid contact with eyes, skin or clothing. Do not breathe vapours or mist. Do not ingest.
Do not smoke or eat while handling the product. Wash thoroughly after handling. The
containers should be stored in their original boxes when not in use.
Storage : Store in closed containers in a cool, dry, well-ventilated area, below 25°C and away from oxidisers, heat, sparks and open flame. Protect containers from physical damage and light.
Keep container closed when not in use. Do not transfer contents to unlabelled containers.
Use only with adequate ventilation. Keep out of reach of children.
8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Component - Occupational Exposure Standard
Procaine hydrochloride Not Established
Adrenaline Not Established
For pure procaine hydrochloride:
LD50 ( Oral,mouse ) 186 mg/kg
LD50 ( Oral,rat ) 74 mg/kg
For pure adrenaline:
LD50 ( Oral,mouse ) 5 mg/kg
Protective Equipment : Wear vinyl, nitrile or rubber gloves, a waterproof bib-apron and suitable eye
protection when applying the product.
9. PHYSICAL AND CHEMICAL PROPERTIES
Form : Bright solution
Colour : Almost colourless
Odour : None.
10. STABILITY AND REACTIVITY
Stability : Stable under normal temperatures and pressures.
Conditions to avoid : None known
Materials to avoid : None known
11. TOXICOLOGICAL INFORMATION
Exposure Effects ( Acute )
Eye Contact : Direct contact of the solution with eyes can cause irritation.
Skin Contact : Prolonged or repeated contact with Adrenocaine Injection may cause irritation
and/or drying and cracking of the skin.
Inhalation : None known.
Ingestion : Oral toxicity of the Adrenocaine Injection is low.
Exposure Effects ( Chronic )
Unknown for the product mixture. When this product is used according to the
directions, prolonged exposure of man is not expected. Both its mutagenicity
and its teratogenicity are not known.
12. ECOLOGICAL INFORMATION
Data on the ecological implications for Adrenocaine Injection is not yet available.
13. DISPOSAL CONSIDERATIONS
Product/Residues : Do not discharge the product material into surface or waste water. For
disposal, use an incinerator licensed for chemical waste.
Package : Dispose of waste containers using regular disposal methods in accordance
with local and national environmental regulations.
14. TRANSPORT INFORMATION
Land, Sea & Air Transport
ADR/RID, IMO/IMDG, IATA/ICAO, UN No. : Not applicable
15. REGULATORY INFORMATION
Labelling Information : None
Safety phrases : S2 Keep out of reach of children
S7 Keep container tightly closed
16. OTHER INFORMATION
Vm : 2000/4243 For Animal Treatment Only
ML : 2000/01
Revision Date : 14/05/10
Revision No : 04
Printing Date : 08/07/2010
Suppliers data sheets and various chemicals and pharmaceuticals databases were used to compile this sheet.
The information contained in this PSDS is believed to be accurate and represents the best information available at the time of preparation. However Norbrook Laboratories Limited makes no warranty, express or implied, with respect to such information and assumes no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes, and Norbrook Laboratories Limited will not be held liable for any damage resulting from the handling of or contact with the above product.
All prices include VAT where applicable.
There are currently no questions for Norbrook Dehorning and Debudding Adrenacaine Injection - be the first to ask one!Ask A Question
Sorry that this product is out of stock, instead of having to keep checking back to see if we have it, we can send you a notification as soon as it comes back in stock.
We won't use any details you enter for any other purpose than letting you know when this is back in stock.
Please enter details for each method you'd like us to notify you by:
VioPoints are a way for us to say thank you for purchasing from VioVet.
You will receive VioPoints by purchasing this product, which can be redeemed for a discount on future purchases. For each 1000 points redeemed at the checkout, you will receive a 20p discount.
The number of VioPoints is shown on the product listing and they are awarded on dispatch of the order.
Terms and conditions apply.